New assessment of the prognostic significance of histopathology in Hodgkin's disease for laparotomy-negative stage I and stage II patients. 1977

L M Fuller, and H Madoc-Jones, and J F Gamble, and J J Butler, and M P Sullivan, and C H Fernandez, and E A Gehan

This paper describes preliminary radiotherapy results in 90 patients with Stage I and II Hodgkin's disease who were evaluated by laparotomy, including splenectomy, and liver and bone marrow biopsies. As a result of selection by laparotomy, the estimated five-year survival rate for these patients was 96%. No statistically significant differences were detected in the disease-free survival for patients with mixed cellularity, nodular sclerosis, and lymphocytic predominance disease. Since only one patient with lymphocytic depletion was in this series, no statement can be made regarding this rare histopathology. Patterns of new disease differed for Stage I and II patients. The major difference was that patients with nodular sclerosing Stage II presentations involving the mediastinum were at considerable risk of developing subsequent disease in the pulmonary parenchyma or the pleura. This finding, together with the demonstration that a histologic diagnosis of mixed cellularity did not carry an inferior prognosis, indicates the need for reassessment of the appropriateness of applying treatment programs based on results of lymphangiographically staged patients to Stage I and II patients evaluated by laparotomy.

UI MeSH Term Description Entries
D007813 Laparotomy Incision into the side of the abdomen between the ribs and pelvis. Minilaparotomy,Laparotomies,Minilaparotomies
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008297 Male Males
D008466 Mechlorethamine A biologic alkylating agent that exerts its cytotoxic effects by forming DNA ADDUCTS and DNA interstrand crosslinks, thereby inhibiting rapidly proliferating cells. The hydrochloride is an antineoplastic agent used to treat HODGKIN DISEASE and LYMPHOMA. Chlorethazine,Chlormethine,Mechlorethamine Oxide,Mustine,Nitrogen Mustard,Nitrogen Mustard N-Oxide,Bis(2-chloroethyl)methylamine,Caryolysine,Cloramin,Embichin,Mechlorethamine Hydrochloride,Mechlorethamine Hydrochloride N-Oxide,Mechlorethamine N-Oxide,Methylchlorethamine,Mitomen,Mustargen,NSC-10107,NSC-762,Nitrogranulogen,Nitromin,Hydrochloride N-Oxide, Mechlorethamine,Hydrochloride, Mechlorethamine,Mechlorethamine Hydrochloride N Oxide,Mechlorethamine N Oxide,N-Oxide, Mechlorethamine Hydrochloride,N-Oxide, Nitrogen Mustard,NSC 10107,NSC 762,NSC10107,NSC762,Nitrogen Mustard N Oxide
D008479 Mediastinal Neoplasms Tumors or cancer of the MEDIASTINUM. Cancer of Mediastinum,Mediastinal Cancer,Cancer of the Mediastinum,Mediastinum Cancer,Mediastinum Neoplasms,Neoplasms, Mediastinal,Cancer, Mediastinal,Cancer, Mediastinum,Cancers, Mediastinal,Cancers, Mediastinum,Mediastinal Cancers,Mediastinal Neoplasm,Mediastinum Cancers,Mediastinum Neoplasm,Neoplasm, Mediastinal,Neoplasm, Mediastinum,Neoplasms, Mediastinum
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010997 Pleural Neoplasms Neoplasms of the thin serous membrane that envelopes the lungs and lines the thoracic cavity. Pleural neoplasms are exceedingly rare and are usually not diagnosed until they are advanced because in the early stages they produce no symptoms. Neoplasms, Pleural,Neoplasm, Pleural,Pleural Neoplasm
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D011344 Procarbazine An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease. Matulane,Natulan,Procarbazine Hydrochloride,Procarbazine Monohydrobromide,Procarbazine Monohydrochloride,Hydrochloride, Procarbazine,Monohydrobromide, Procarbazine,Monohydrochloride, Procarbazine

Related Publications

L M Fuller, and H Madoc-Jones, and J F Gamble, and J J Butler, and M P Sullivan, and C H Fernandez, and E A Gehan
January 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
L M Fuller, and H Madoc-Jones, and J F Gamble, and J J Butler, and M P Sullivan, and C H Fernandez, and E A Gehan
April 1982, Cancer treatment reports,
L M Fuller, and H Madoc-Jones, and J F Gamble, and J J Butler, and M P Sullivan, and C H Fernandez, and E A Gehan
January 1998, International journal of radiation oncology, biology, physics,
L M Fuller, and H Madoc-Jones, and J F Gamble, and J J Butler, and M P Sullivan, and C H Fernandez, and E A Gehan
November 1977, Scandinavian journal of haematology,
L M Fuller, and H Madoc-Jones, and J F Gamble, and J J Butler, and M P Sullivan, and C H Fernandez, and E A Gehan
April 1986, Scandinavian journal of haematology,
L M Fuller, and H Madoc-Jones, and J F Gamble, and J J Butler, and M P Sullivan, and C H Fernandez, and E A Gehan
January 1965, Acta pathologica et microbiologica Scandinavica,
L M Fuller, and H Madoc-Jones, and J F Gamble, and J J Butler, and M P Sullivan, and C H Fernandez, and E A Gehan
January 1986, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,
L M Fuller, and H Madoc-Jones, and J F Gamble, and J J Butler, and M P Sullivan, and C H Fernandez, and E A Gehan
April 1984, Lancet (London, England),
L M Fuller, and H Madoc-Jones, and J F Gamble, and J J Butler, and M P Sullivan, and C H Fernandez, and E A Gehan
October 1991, Cancer,
L M Fuller, and H Madoc-Jones, and J F Gamble, and J J Butler, and M P Sullivan, and C H Fernandez, and E A Gehan
July 1978, Nederlands tijdschrift voor geneeskunde,
Copied contents to your clipboard!